Cyclin-Dependent Kinase 4/6 Inhibitors, Margetuximab, Trastuzumab Deruxtecan, and Tyrosine Kinase Inhibitors Have Shown Promising Results
William Ray Stevens, PharmD Candidate
Advertisement
Articles by William Ray Stevens, PharmD Candidate
Advertisement
Latest Updated Articles
What Are the Newest Breast Cancer Treatment Options?Published: September 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Integrating Combination Therapies for Type 2 Diabetes and CKD
2
Building a Unified Approach to Cardio Kidney Metabolic Health
3
Sotatercept Demonstrates Significant Reduction in Morbidity and Mortality Across Broader PAH Risk Groups
4
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
5
